Kymera Stock 130%: $135 Million Buy Boosts Immunology Bet
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
We evaluate long-term return potential across index funds to help you identify candidates with the strongest growth prospects.
28,522 articlesA major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
Broadcom is shifting from a broad tech portfolio to a focused AI chip powerhouse. If the company can turn custom AI c...
In a volatile session, AT&T tumbled after a Supreme Court ruling favored the FCC on a data-privacy case, while major ...
A bold XRP price target sparked renewed debate after a viral prompt. AI analysis shows the path to $48 hinges on a ra...
Retail investors push Ford into meme-stock territory as Wall Street holds, sparking a heated debate about the automak...
X-Energy stock faced a sharp 19.2% drop this week after project delays and a downgrade. This article breaks down the ...
Anthropic and Airbnb are placing big bets on New York City, expanding footprints and hiring aggressively while critic...
Three high-variance names—Moderna, Trade Desk, and MicroStrategy—reversed declines to rally in early March, signaling...
Asia is turning to U.S. LNG suppliers as disruptions in the Middle East squeeze global gas flows. The response is swi...
Discover what the (sfl) 2026 earnings call implies for revenue trends, balance sheet health, and the road ahead. This...
Oil prices have cooled, yet a veteran observer warns that upside risks could re-emerge. OPEC+ supply increases, Hormu...
Flotek's 2025 earnings outlook hinges on energy demand, cost control, and segment mix. This guide breaks down what to...